Bioceres Crop Solutions vs Scotts Miracle-Gro
BIOX and SMG side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BIOX and SMG compare
Scotts Miracle-Gro grew revenue faster over the last twelve months (4.6% versus −17.7% for Bioceres Crop Solutions).
Scotts Miracle-Gro pays a dividend yielding 4.1%; Bioceres Crop Solutions does not pay one.
Scotts Miracle-Gro scores higher on the StockData Score (12 against 1 for Bioceres Crop Solutions), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BIOX | SMG |
|---|---|---|
| Size and price | ||
| Market cap | – | $3.8B |
| Share price | $0.233 | $65.04 |
| Change, 1 year | −86.6% | 14.2% |
| Change, 5 years | −98.5% | −60.8% |
| Beta (5Y) | 0.76 | 1.30 |
| Employees | 562 | 5,200 |
| StockData Score | ||
| Total score | 1 | 12 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 1 | 1 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | – | 53.8× |
| P/S | – | 1.1× |
| EV/EBITDA | – | 15.4× |
| P/FCF | – | 14.4× |
| FCF yield | – | 7.0% |
| Fair value | – | $51.84 |
| Margin of safety | – | −25.5% |
| Growth | ||
| Revenue growth (TTM) | −17.7% | 4.6% (better) |
| Revenue growth, 5Y average | 2.6% (better) | −3.7% |
| EPS growth, 5Y average | – | −18.4% |
| Profitability | ||
| Gross margin | 34.9% (better) | 31.8% |
| Operating margin | −9.8% | 11.0% (better) |
| Net margin | – | 2.1% |
| FCF margin | 27.3% (better) | 7.6% |
| Return on invested capital | −7.4% | 12.3% (better) |
| Financial health | ||
| Debt / equity | 10.01 | – |
| Net debt / EBITDA | – | 5.45 |
| Interest coverage | −0.6× | 3.4× (better) |
| Current ratio | 0.80 | 1.21 (better) |
| Altman Z-score | – | 2.44 |
| Piotroski F-score | – | 7 |
| Dividends and buybacks | ||
| Dividend yield | – | 4.1% |
| Payout ratio | – | 209% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | −18.5% |
| Buyback yield | – | 0.32% |
| Shareholder yield | – | 4.4% |
| Ownership | ||
| Held by institutions | 13.2% | 86.5% |
| Held by insiders | 73.3% | 53.4% |
| Insider net buying, 12 months | – | −$5.4M |
| Short interest, % of float | 2.7% | 19.0% |
Go deeper
- BIOX stock overview
- BIOX income statement
- BIOX valuation and score
- SMG stock overview
- SMG income statement
- SMG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.